消化管穿孔性腹膜炎とエンドトキシン吸着療法

概要

論文の詳細を見る
We used PMX-20 R in the treatment of 20 septic shock patients who developed complicated multiple organ failure caused by intestinal perforation. Extracorporeal circulation was performed for 120 min with a blood flow of 80-120 ml/min. In this treatment, we assessed changes in the patients' hemodynamics and the levels of cytokine (TNF, IL-6, IL-1 ra and IL-10), soluble ICAM-1, thrombomodurin, NO_x and PAI-1 during and after hemoperfusion using PMX-20 R. Before the treatment, the mean APACHE-II score of the 20 patients was 24.3, mean septic severity score was 46.9, and Goris score was, 4.7. Mean arterial BP and LVSWI after the treatment increased compared to the values in similar patients who did not receive this treatment while our patients showed a slight decrease in platelet counts. The values of the endospecy test (the new PCA method) apparently declined at the end of PMX treatment. The two inflammatory cytokines, TNF-α and IL-6, and the anti-inflammatory cytokines, IL-1 ra and IL-10, decreased immediately after PMX and at 24 h after completing PMX. On the other hand, the levels of ICAM-1, thrombomodurin, NO_x did not decline. PAI-1 decreased remarkably at the end of PMX and 24 h after PMX. As a result, 15 of the 20 patients has good prognosis and 5 had poor prognosis. Therefore, hemoperfusion with PMX-20 R could be a useful therapeutic measure for patients with septic shock caused by intestinal perforation, and it is recommended that this treatment should be begun as quickly as possible after emergency surgiccal treatment.
日本アフェレシス学会の論文
1999-02-28

消化管穿孔性腹膜炎とエンドトキシン吸着療法

スポンサーリンク

概要

著者

関連論文

スポンサーリンク